Skip to content

Clinical trials

Completed Phase 1 Rheumatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Phase: Phase 1 Status: Completed Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20161
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Kang Stem Biotech Co., Ltd.1
Kinevant Sciences GmbH1
MedImmune LLC1
Russian Academy of Medical Sciences1
Sandoz1
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases7
Arthritis, Rheumatoid3
Autoimmune Diseases3
Arthritis2
Connective Tissue Diseases2
Immune System Diseases2
Joint Diseases2
Musculoskeletal Diseases2
Inflammation1
Spondylitis, Ankylosing1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.